IQVIA
Jeffrey S. is a highly experienced executive in the medical and scientific field, currently serving as Senior Vice President and Global Chief Medical and Scientific Officer at IQVIA since August 2011, where responsibilities include resolving complex scientific and medical issues, overseeing global quality assurance, and managing an annual budget of approximately $20 million. Prior to this role, Jeffrey held senior positions at Quintiles and Takeda, contributing significantly to the development of medical affairs strategies and clinical oversight in various therapeutic areas, including a $1 billion cardio-metabolic franchise at Takeda. Experience spans other esteemed organizations, including Abbott Laboratories and Johns Hopkins HealthCare, where innovative approaches and strategic leadership in clinical development and telemedicine were implemented. Educational credentials include an MBA from Northwestern University's Kellogg School of Management, an MD from The Johns Hopkins University School of Medicine, and a BS in Engineering Science from Penn State University.
This person is not in any teams
This person is not in any offices
IQVIA
164 followers
IQVIA, formerly Quintiles IMS Holdings, Inc., is an American multinational company serving the combined industries of health information technologies and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.